ClinicalTrials.Veeva

Menu

Vitamin D Status in Children With Sickle Cell Disease Living in Lyon, France (EVADDREP)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Vitamin D Deficiency
Sickle Cell Disease

Treatments

Biological: 25-OH Vitamin D measure

Study type

Observational

Funder types

Other

Identifiers

NCT04694976
69HCL20_0885
ID-RCB (Other Identifier)

Details and patient eligibility

About

Vitamin D deficiency may be under-diagnosed in sickle cell disease French children. Therefore, the investigator need an epidemiologic study about the prevalence of vitamin D deficiency in this specific population. There are not specific guidelines neither testing nor treatment. The investigator propose to test vitamin D status in all children with sickle cell disease who are consulting their referring haematologist doctor or in the emergency ward.

Enrollment

130 patients

Sex

All

Ages

Under 17 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children: under 18 years old
  • Sickle cell any genetic type homozygous or composite heterozygous
  • To receive an assessment independently of the study, during a presentation to the emergency ward and/or a follow-up consultation by the hematologist
  • no parental opposition signed by at least one parent/legal representative and no child opposition
  • social security beneficiary

Exclusion criteria

  • History of hematologic grafting

Trial design

130 participants in 1 patient group

Sickle cell disease children from Lyon, France
Description:
Sickle cell disease children, followed in IHOPe (Institut d'Hématologie et d'Oncologie Pédiatrique) center, consulting their referring haematologist doctor or in emergency ward, with prescribed blood sample.
Treatment:
Biological: 25-OH Vitamin D measure

Trial contacts and locations

1

Loading...

Central trial contact

Valérie LAUNAY, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems